Chemoinformaics analysis of CIS-1,3-PENTADIENE
| Molecular Weight | 68.119 | nRot | 1 |
| Heavy Atom Molecular Weight | 60.055 | nRig | 2 |
| Exact Molecular Weight | 68.0626 | nRing | 0 |
| Solubility: LogS | -2.092 | nHRing | 0 |
| Solubility: LogP | 2.228 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 13 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 5 | No. of Aromatic Carbocycles | 0 |
| nHetero | 0 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 8 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 5 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 0 | No. of Arom Bond | 0 |
| nHA | 0 | APOL | 13.6843 |
| nHD | 0 | BPOL | 8.02566 |
| QED | 0.411 |
| Synth | 3.592 |
| Natural Product Likeliness | 2.127 |
| NR-PPAR-gamma | 0.006 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0 |
| Pgp-sub | 0.012 |
| HIA | 0.004 |
| CACO-2 | -4.231 |
| MDCK | 0.0000338 |
| BBB | 0.978 |
| PPB | 0.426267 |
| VDSS | 1.258 |
| FU | 0.577103 |
| CYP1A2-inh | 0.226 |
| CYP1A2-sub | 0.611 |
| CYP2c19-inh | 0.05 |
| CYP2c19-sub | 0.898 |
| CYP2c9-inh | 0.013 |
| CYP2c9-sub | 0.644 |
| CYP2d6-inh | 0.021 |
| CYP2d6-sub | 0.894 |
| CYP3a4-inh | 0.007 |
| CYP3a4-sub | 0.271 |
| CL | 8.582 |
| T12 | 0.731 |
| hERG | 0.009 |
| Ames | 0.779 |
| ROA | 0.382 |
| SkinSen | 0.951 |
| Carcinogencity | 0.854 |
| EI | 0.996 |
| Respiratory | 0.969 |
| NR-Aromatase | 0.046 |
| Antiviral | No |
| Prediction | 0.956861 |